Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease

NCT04308551 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped shortage of funds

Conditions

Stable Coronary Heart Disease

Interventions

DRUG: Indobufen
DRUG: Aspirin

Sponsor

Henan Institute of Cardiovascular Epidemiology